VERA (Vera Therapeutics, Inc. Class A Common Stock) Stock Analysis - Politician Trades
Vera Therapeutics, Inc. Class A Common Stock (VERA) is a publicly traded Healthcare sector company. As of May 21, 2026, VERA trades at $34.67 with a market cap of $2.47B and a P/E ratio of -7.31. VERA moved +4.15% today. Year to date, VERA is -26.45%; over the trailing twelve months it is +62.99%. Its 52-week range spans $18.53 to $56.05. Analyst consensus is strong buy with an average price target of $77.67. Rallies surfaces VERA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded VERA stock?
Rallies tracks politician and congressional stock disclosures for VERA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for VERA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in VERA?
Yes. Rallies tracks politician and congressional stock disclosures for VERA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is VERA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VERA. It does not provide personalized investment advice.